ACTH-related peptides, kindling and seizure disorders
- PMID: 3035892
ACTH-related peptides, kindling and seizure disorders
Abstract
Very small amounts of pituitary hormones and their peptide fragments can profoundly affect learning, memory and other behaviors in both rodents and humans. In addition, several potent pituitary hormone analogs have been developed (e.g. ORG-2766) which retain the behavioral but not the endocrine properties of the parent hormone. The abilities of these peptides to influence nervous system functions suggested that they also may be capable of modifying seizure activity. This possibility is supported by the fact that treatment with adrenocorticotropic hormone (ACTH) represents a major effective therapy for at least one clinical convulsive disorder, infantile spasm. This contention also is reinforced by our findings that ORG-2766 markedly reduces both the behavioral severity and the spread of seizure potentials in an animal model of epilepsy, the kindled rat. By contrast, arginine vasopressin and its non-endocrine desglycyl fragment (DGAVP) facilitates the seizure process in this animal model. Our research also suggests that the behavioral and physiological effects of certain anterior and posterior pituitary hormone fragments depend, in part, on their abilities to modulate permeability mechanisms in brain vasculature. In addition, and especially significant from the standpoint of etiology, is the observation that the kindling process itself appears to alter cerebrovascular permeability. In the kindled rat, "permanent" decreases in permeability (60-75%) are found selectively in the hypothalamic and hippocampal regions, weeks after the last seizure. Several lines of evidence indicate that disruption of normal cerebrovascular function occurs following epileptiform seizures. We propose that an immediate increase in cerebral blood flow and cerebrovascular permeability occurs following a single, acute seizure, and that repeated chronic seizures lead to damage to the cerebrovascular system. Sustained damage would be expected to contribute to the development and maintenance of a chronic seizure focus. Such observations suggest a link between important cerebrovascular disturbances associated with seizures and the existing known and proposed electrophysiological, metabolic and neuropathological substrates of epilepsy. They also point to new strategies for the treatment of seizure disorders by focusing on ways to reduce or prevent cerebrovascular damage.
Similar articles
-
Reduction of amygdaloid kindled seizures by an analog of ACTH/MSH.Peptides. 1984 Nov-Dec;5(6):1061-5. doi: 10.1016/0196-9781(84)90171-2. Peptides. 1984. PMID: 6099557
-
Neuropeptides: anticonvulsant and convulsant mechanisms in epileptic model systems and in humans.Adv Neurol. 1986;44:489-500. Adv Neurol. 1986. PMID: 2871723 Review.
-
Seizure-induced alterations in the metabolism of hippocampal opioid peptides suggest opioid modulation of seizure-related behaviors.NIDA Res Monogr. 1988;82:48-66. NIDA Res Monogr. 1988. PMID: 2899842 Review.
-
Intranasal delivery of a thyrotropin-releasing hormone analog attenuates seizures in the amygdala-kindled rat.Epilepsia. 2007 Dec;48(12):2280-6. doi: 10.1111/j.1528-1167.2007.01218.x. Epub 2007 Jul 25. Epilepsia. 2007. PMID: 17651414
-
Modulation of opioid peptide metabolism by seizures: differentiation of opioid subclasses.NIDA Res Monogr. 1986;71:89-101. NIDA Res Monogr. 1986. PMID: 3025738
Cited by
-
Evaluation of local cerebral glucose utilization and the permeability of the blood-brain barrier in the genetically epilepsy-prone rat.Exp Brain Res. 1992;88(1):151-7. doi: 10.1007/BF02259136. Exp Brain Res. 1992. PMID: 1541351